Menu
Close
Stories & News
Resources
Stay Informed
x
Stay Informed
April 8, 2024
In March, Pfizer released it’s 2023 Impact Report, which demonstrates the company's dedication to its Environmental, Social and Governance (ESG) priority areas and advancing progress towards sustainability goals.
“It reflects our dedication to being a force for good in the world by acting with integrity, holding ourselves to high standards, being accountable to our commitments, and addressing shortcomings candidly and with specific plans for improvement,” said Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer.
Pfizer's ESG efforts align with the company's commitment to achieving its Purpose – breakthroughs that change patients' lives.
Did you check out Pfizer’s 2023 Impact Report? Quiz your knowledge below!
Thank you for participating in our quiz.
1 The Patients Treated metric is calculated from Pfizer and third-party datasets. This metric excludes data from Seagen Inc., which was acquired by Pfizer in December 2023. Figures may be limited given the coverage provided by external sources (e.g., calendar duration, geographic and product coverage) and are subject to change. Numbers are estimates and in some cases use global volume, daily dosage and number of treatment days to facilitate calculations. Methodologies to calculate estimates may vary by product type given the nature of the product and available data. Patients taking multiple Pfizer products may be counted as multiple patients towards total. Numbers do not include comprehensive estimated patient counts from Ex-US Access & Affordability programs (this does not include An Accord for a Healthier World). Historical estimates may periodically be subject to revision due to restatements in the underlying data source.
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at www.pfizer.com. and the SEC’s website at www.sec.gov. Please also refer to our 2023 Impact Report, which is available on our website at www.pfizer.com..
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.
Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.